• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.44% Nasdaq Down0.37%

    Halozyme Therapeutics, Inc. (HALO)

    17.80 Down 0.14(0.78%) Nov 30, 4:00PM EST
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.3
    Mean Recommendation (last week):2.3

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:23.00
    Median Target:25.00
    High Target:28.00
    Low Target:7.00
    No. of Brokers:8

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Dec 24, 2014MLV & CoInitiated Buy
    Jun 12, 2014UBSUpgradeNeutralBuy
    Aug 2, 2013BarclaysDowngradeOverweightEqual Weight
    Apr 1, 2011Stifel NicolausInitiated Buy
    Oct 19, 2010JMP SecuritiesInitiated Mkt Perform
    Oct 6, 2010Barclays CapitalInitiated Overweight
    Apr 8, 2010William BlairInitiated Outperform
    Mar 22, 2010Brean MurrayUpgradeHoldBuy
    Oct 13, 2009Wedbush MorganUpgradeNeutralOutperform
    Apr 29, 2009Roth CapitalUpgradeHoldBuy

    More Upgrades & Downgrades for HALO

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0001

    Data provided by Thomson/First Call

    Currency in USD.